The Manitoba Drug Benefits and Interchangeability Formulary lists therapeutically effective drugs of proven high quality that have been approved as eligible benefits under the Pharmacare drug benefit program.  It also includes a list of interchangeable drugs.  It is compiled with the advice of the Manitoba Drug Standards and Therapeutics Committee, assisted by Manitoba Health staff and outside consultants.  The Minister of Health gives the final approval for benefits under the Pharmacare drug benefit program.

Updates to the Manitoba Formulary are made available every three to four months by bulletin and via this website.  Copies of the Manitoba Formulary and the updates are also available at the Queen’s Printer (Manitoba) Statutory Publications, 200 Vaughan Street, Winnipeg, Manitoba, R3C 1T5, telephone (204) 945-3101 in Winnipeg, toll free 1-800-231-1203, fax (204) 945-7172. Note: In the case of discrepancies between the versions of documents on this website and the official versions as published by the Queen’s Printer (Manitoba) Statutory Publications, the official versions will prevail.

Each new Formulary has three components:  a new Bulletin, a revised Specified Drugs Regulation (Parts 1 and 2) made under The Prescription Drugs Cost Assistance Act, and a revised Manitoba Drug Interchangeability Formulary.  A listing of pharmaceutical manufacturer abbreviations is also provided below.

These documents require knowledgeable interpretation and are intended primarily for use by professional health care practitioners, pharmacies, hospitals, and organizations associated with the manufacture, distribution and use of pharmaceutical preparations.

Please note:  you will need the Adobe Acrobat Reader to view PDF documents.
If you do not have the Adobe Acrobat Reader installed on your computer, please click here:

Bulletin #53 Amendments to the Manitoba Drug Benefits and Interchangeability Formulary.  Effective Date:  December 14, 2006 Specified Drugs Regulation (Parts 1 and 2) This is the regulation that provides for the benefit lists of specified drugs under the Prescription Drugs Cost Assistance Act.  It lists the drugs and criteria for eligibility for the Manitoba Pharmacare program. Effective Date: September 14, 2006 Manitoba Drug Interchangeability Formulary Regulation This regulation includes a list of interchangeable drugs, categories and prices under The Pharmaceutical Act.  Please note that Manitoba Pharmacare will reimburse only up to the level of the lowest price in an interchangeable category for those interchangeable drugs which are Pharmacare benefits. Effective Date: September 14, 2006 Changes to Pharmacare & Family Services Drug Programs benefit coverage for Proton Pump Inhibitors effective March 13, 2006 Since their introduction, Proton Pump Inhibitors (PPIs) have been in increasing demand. Although they are extremely effective medications, the wide spread use of PPIs exerts significant cost pressure on Pharmacare and Family Services Drug Programs and on consumers. As a result, Pharmacare and Family Services Drug Programs are changing the way they provide benefit coverage of the PPIs.   Effective Date:  March 13, 2006 Information Sheet for Health Professionals - Move Into Part 3 Exception Drug Status (Eds) Proton Pump Inhibitors (PPI’s) For Pharmacare And Family Services Clients Effective March 13, 2006, all Pharmacare and Family Services Drug Program clients being started on a PPI will require Part 3 Exception Drug Status (EDS) approval to receive drug program benefits. Effective Date:  March 13, 2006
	Manufacturer Abbreviations An index of pharmaceutical manufacturer abbreviations used in the Manitoba Drug Interchangeability Formulary. Revised:  October, 2005 8 pages
	Changes to Pharmacare benefit coverage for COX-2 Inhibitors Effective September 1, 2004, Pharmacare will implement a change in the benefit status for the class of COX-2 drugs (Celebrex, Mobicox and Vioxx generic meloxicam), from Part 2 to Part 3. COX-2 Inhibitors will be required to meet established EDS criteria for the treatment of osteoarthritis and rheumatoid arthritis. Effective Date: September 1, 2004
	Product Identification Number listing A product identification listing for non-prescription products. Revised:  September 2003 7 pages
(Veuillez noter que les documents sont offert en anglais seulement.)